Dr. Pranatharthi H. Chandrasekar, MD

Dr. Chandrasekar practices at Karmanos Cancer Center - Detroit in Detroit, Michigan.

Dr. Chandrasekar's NPI, 1861430944, was assigned on June 2, 2006. Dr. Chandrasekar holds Michigan license 4301046420.

Dr. Chandrasekar's primary practice is Karmanos Cancer Center - Detroit, at 4100 John R St, Detroit, MI 48201 in Wayne County. The practice phone is (800) 527-6266.

Dr. Chandrasekar's primary practice is Karmanos Cancer Center - Detroit in Detroit, Michigan. The medical group on file is Wayne Health. Dmand AI also links Dr. Chandrasekar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chandrasekar practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Chandrasekar's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Chandrasekar is licensed in Michigan.

CMS data shows 187 Medicare services from Dr. Chandrasekar across 6 procedure codes in 2024, for 72 Medicare patients. Medicare paid $13,167 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Chandrasekar in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chandrasekar's median patient age at 67, with 57% women.

In 2024, Dr. Chandrasekar wrote 25 Medicare Part D claims. 76% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $162 in total drug cost. In 2022, CMS named 16 claims across 1 drug.

Dmand AI links 80 papers to Dr. Chandrasekar, published from 2005 to 2024. 2021 was the busiest year, with 7. The most frequent topics are Antifungal Agents, Hematopoietic Stem Cell Transplantation and Anti-Bacterial Agents. Dr. Chandrasekar has published most often in Open Forum Infect Dis. Dr. Chandrasekar's most frequent co-authors are George J. Alangaden, MD, Marisa Haydee Miceli, MD and Teena Chopra, MD.

Dmand AI links Dr. Chandrasekar to 1 clinical trial.

CMS Open Payments shows 154 general payments to Dr. Chandrasekar from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 48% of the total. Astellas Pharma US Inc paid the most, $83,018. It also lists 1 research payment totaling $5,074 in 2017.